Teva Pharmaceutical Industries Ltd (TEVA) stock, explained like you're 5

Is Teva Pharmaceutical Industries Ltd a small, medium or large cap company?

Yes. Teva Pharmaceutical Industries Ltd is a large cap stock. Its market cap, which is the total value of all its shares, is about 47.9 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Teva Pharmaceutical Industries Ltd makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves TEVA stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended Release Injectable Suspension, as the First and Only Once Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia (Teva Pharmaceuticals)
• TEVA Stock Alert: What to Know as Teva Therapeutics' Scores FDA Approval for Schizophrenia Treament (Yahoo Finance)
• Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment (Stocktwits)
• Teva leaders will discuss medicines in development and the company's potential over five years. (Stock Titan)
• Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co. (MarketBeat)

Key terms to know before you follow TEVA

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility